234 related articles for article (PubMed ID: 18644685)
1. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
Farren CK; Scimeca M; Wu R; Malley SO
Drug Alcohol Depend; 2009 Jan; 99(1-3):317-21. PubMed ID: 18644685
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.
O'Malley SS; Robin RW; Levenson AL; GreyWolf I; Chance LE; Hodgkinson CA; Romano D; Robinson J; Meandzija B; Stillner V; Wu R; Goldman D
Alcohol Clin Exp Res; 2008 Jul; 32(7):1271-83. PubMed ID: 18482155
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.
Pettinati HM; Oslin DW; Kampman KM; Dundon WD; Xie H; Gallis TL; Dackis CA; O'Brien CP
Am J Psychiatry; 2010 Jun; 167(6):668-75. PubMed ID: 20231324
[TBL] [Abstract][Full Text] [Related]
4. A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence.
Farren CK; O'Malley S
Am J Addict; 2002; 11(3):228-34. PubMed ID: 12202015
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
Anton RF; Oroszi G; O'Malley S; Couper D; Swift R; Pettinati H; Goldman D
Arch Gen Psychiatry; 2008 Feb; 65(2):135-44. PubMed ID: 18250251
[TBL] [Abstract][Full Text] [Related]
7. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.
Oliveto A; Poling J; Mancino MJ; Williams DK; Thostenson J; Pruzinsky R; Gonsai K; Sofuoglu M; Gonzalez G; Tripathi S; Kosten TR
Addiction; 2012 Jan; 107(1):131-41. PubMed ID: 21707811
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
[TBL] [Abstract][Full Text] [Related]
9. Extended naltrexone and broad spectrum treatment or motivational enhancement therapy.
Longabaugh R; Wirtz PW; Gulliver SB; Davidson D
Psychopharmacology (Berl); 2009 Oct; 206(3):367-76. PubMed ID: 19639303
[TBL] [Abstract][Full Text] [Related]
10. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.
Moak DH; Anton RF; Latham PK; Voronin KE; Waid RL; Durazo-Arvizu R
J Clin Psychopharmacol; 2003 Dec; 23(6):553-62. PubMed ID: 14624185
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.
Kranzler HR; Modesto-Lowe V; Van Kirk J
Neuropsychopharmacology; 2000 May; 22(5):493-503. PubMed ID: 10731624
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.
Garbutt JC; Kranzler HR; O'Malley SS; Gastfriend DR; Pettinati HM; Silverman BL; Loewy JW; Ehrich EW;
JAMA; 2005 Apr; 293(13):1617-25. PubMed ID: 15811981
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone in the treatment of alcohol dependence.
Krystal JH; Cramer JA; Krol WF; Kirk GF; Rosenheck RA;
N Engl J Med; 2001 Dec; 345(24):1734-9. PubMed ID: 11742047
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
Mancino MJ; McGaugh J; Chopra MP; Guise JB; Cargile C; Williams DK; Thostenson J; Kosten TR; Sanders N; Oliveto A
J Clin Psychopharmacol; 2014 Apr; 34(2):234-9. PubMed ID: 24525654
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone for alcohol-dependent patients.
Ahmadi J; Babaeebeigi M; Maany I; Porter J; Mohagheghzadeh M; Ahmadi N; Dehbozorgi G
Ir J Med Sci; 2004; 173(1):34-7. PubMed ID: 15732235
[TBL] [Abstract][Full Text] [Related]
18. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
Mason BJ; Salvato FR; Williams LD; Ritvo EC; Cutler RB
Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606
[TBL] [Abstract][Full Text] [Related]
20. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B
Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
